The finding of a significant relationship between leptin and TGF-β1 levels in our patients is consistent with previous studies that showed that leptin binds to leptin receptors on the surface of cancer cells, activates JAK/STAT3 signaling, and consequently increases TGF-β expression21. The gene discussed is LEPR; the disease is cancer.